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Objective: This study was designed to get epidemiological characteris-
tics, etiology characteristics, prognosis assessment and prognostic factors 
of hospital-acquired bloodstream infection (HABSI) in the elderly in 
Chinese PLA General Hospital and aimed at providing a reference for 
HABSI in the elderly on clinical diagnosis and treatment to improve the 
prognosis. Methods: The clinical data and pathology data of 210 cases 
of the elderly patients with HABSI from 2009 to 2012 in geriatric wards 
were retrospectively analyzed. Compare the clinical assessment effects of 
APACHE-II score, SAPS-II score and SOFA score to HABSI prognosis 
in the elderly by plotting the receiver operating characteristic curve. Use 
univariate and multivariate logistic regression analysis to get prognostic 
factors of HABSI in the elderly. Results: Univariate analysis of mortality: 
Day 1 apache -> 18 II score, lung infection, invasive ventilation, chron-
ic hepatic insufficiency, chronic renal insufficiency, substantive organ 
malignant tumor, deep venipuncture, indwelling gastric tube indwelling 
ureter, complicated with shock and acquired bloodstream infections in the 
elderly patients with 7 days survival state association is significant. Day-
1 SOFA score>7, chronic liver dysfunction, chronic renal insufficiency, 
concurrent shock, hemodialysis and 28-day survival status of patients 
with acquired bloodstream infection in elderly hospitals were significantly 
associated. Multivariate unconditioned logistic regression analysis related 
to death: Day-1APACHE-II score>18, parenchymal malignant tumors, 
and concurrent shock are independent risk factors for 7-day death in el-
derly patients with acquired bloodstream infection. Day-1 SOFA score>7, 
chronic renal insufficiency, and concurrent shock are independent risk 
factors for 28-day mortality in elderly patients with acquired bloodstream 
infection. Conclusion: The incidence of acquired bloodstream infections 
in the elderly was 1.37%. The 7-day and 28-day mortality rates were 
8.10% and 22.38%, respectively. Concurrent shock is 26.7%. The 28-
day mortality rate of concurrent shock patients was 48.21%. The best 
outcome score for the 7-day prognosis of elderly patients with acquired 
bloodstream infection was the Day-1APACHE-II score, followed by the 
Day-1 SOFA score. The best score for the 28-day prognostic assessment 
was the Day-1 SOFA score.
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1. Introduction
With the increase of tumor incidence, organ transplantation and aging of population, the number of people with low immunity and im-
munosuppression is increasing. At the same time, various 
invasive diagnosis and treatment techniques are gradu-
ally developed in clinical practice, and the incidence of 
bloodstream infection is gradually increased. Bloodstream 
infection is a serious systemic infectious disease. It not 
only has a high incidence rate, but also has a high mortal-
ity rate and high treatment costs. Bloodstream infection is 
one of the most serious and thorny problems in infectious 
diseases [1-3].
It is estimated that approximately 250,000 Americans 
suffer from hospital-acquired bloodstream infections each 
year [4]. The incidence of hospital-acquired bloodstream 
infections is 0.6% [5], which is one of the most common 
hospital-acquired infections. It accounts for about one-
tenth of hospital-acquired infections. The incidence rate 
is high, the hospital stay is long, and the mortality rate 
is high. It ranks second among the causes of death asso-
ciated with hospital-acquired infections, second only to 
hospital-acquired pneumonia [1-3, 6]. Nosocomial acquired 
bloodstream infection greatly increases the mortality of 
patients. Bueno-cavanillas et al. thought that it increased 
the case fatality rate by 3.13 times [7]. Catheter-related 
bloodstream infection is the most common type of hospi-
tal-acquired bloodstream infection. The case fatality rate 
of catheter-related bloodstream infection reported abroad 
is 12% ~ 25% [8, 9]. In the United States, catheter-related 
bloodstream infections can reach up to 28,000 deaths 
per year and cost $2.3 billion annually [5]. In China, Yang 
Zuyao et al. [10] conducted a meta-analysis of domestic 
related literature published from 1990 to August 2008 and 
found that the mortality rate of bloodstream infection was 
28.7%. According to the epidemiological survey on the 
causes of death in the United States conducted by the cen-
ters for disease control and prevention (CDC), compared 
with the survey results in 1980, sepsis among the causes 
of death in patients of all ages rose to the top 10 [11].
2. Materials and Methods
2.1 Research Object
All patients with blood stream infection in geriatric ward 
of our hospital from January 2009 to December 2012 were 
taken as research objects.
Inclusion criteria: 1) conform to the diagnostic criteria 
for hospital-acquired bloodstream infections (referring to 
China's 2001 Ministry of Health Hospital Infection Diag-
nostic Criteria); 2) ≥65 years old; 3) The medical history 
is complete.
Diagnostic criteria for bloodstream infections: Diag-
nostic Criteria for Nosocomial Infections of the Ministry 
of Health of China in 2001 (Trial)
Clinical diagnosis: Fever >38 °C or hypothermia <36 
°C. Chills may accompany and combine one of the fol-
lowing: 1) Have an invasive portal or migratory lesions; 2) 
Systemic poisoning symptoms without obvious infection 
focus; 3) There were rash or bleeding spots, enlarged liver 
and spleen, and increased neutrophilic granulocytes in 
the blood, accompanied by left nuclear shift, and no other 
reasons could be explained; 4) The systolic blood pressure 
is lower than 12 kPa (90 mmHg), or the original systolic 
pressure drops more than 5.3 kPa (40 mmHg) [12].
Pathogenic diagnosis: One of the following two criteria 
is met: (1) Pathogenic microorganisms were isolated from 
blood culture; (2) The antigenic substance of the pathogen 
is detected in the blood.
Strain identification and drug sensitivity method: 
Bacteria were identified using the French BioMérieux 
VITEK2-Compact microbiological automatic appraisal. 
The fungi were identified by a VITEK2-Compact micro-
biological automatic identification instrument combined 
with manual methods. Drug sensitivity method: The K-B 
method or the MIC method was used for the pathogenic 
drug sensitivity test.
2.2 Research Method
The medical records are retrieved and consulted, and 
the data is recorded using an Excel spreadsheet. The de-
tails are as follows:
(1) General condition of the patient: Name, inpatient 
department, hospital number, ID number, gender, age, 
weight, height, time of bloodstream infection, time of ad-
mission, time of leaving the hospital, etc.;
(2) When bloodstream infection occurs, patients are 
complicated with major basic diseases and invasive medi-
cal procedures:
(3) Cardiovascular diseases: Hypertension, coronary 
atherosclerotic heart disease, arrhythmia, cardiac insuffi-
ciency, etc.;
 (4) Respiratory diseases: COPD, chronic bronchitis, 
emphysema, bronchiectasis, pulmonary interstitial fibro-
sis, etc.;
(5) Digestive system diseases: liver cirrhosis, hepatitis, 
chronic liver dysfunction, biliary system diseases, etc.;
(6) Endocrine system diseases: diabetes, hyperthyroid-
ism, etc.;
(7) Urinary system diseases: acute renal insufficiency, 
chronic renal insufficiency, etc.;
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(8) Neurological diseases: previous cerebral infarction, 
Parkinson's disease, Alzheimer's disease, sequelae of 
stroke, vertebrobasilar insufficiency, etc.
(9) Tumor: hematological tumor, parenchymal malig-
nant tumor, etc.;
(10) Others: indwelling gastric tube, indwelling cathe-
ter, deep vein catheterization, admission to ICU, invasive 
ventilation, hemodialysis, combined antibiotics before 
infection.
(11) Pathogen species, infection pathway, primary tu-
mor, migratory foci, drug susceptibility results, etc.
(12) Vital signs and laboratory tests:
A. Recording time: the worst value of blood flow infec-
tion 24 hours (Day-1) and bloodstream infection 24 hours 
(Day1);
B. Record items: body temperature, blood pressure, 
respiration, pulse, eye reaction, speech response, exercise 
response, chronic health status, application of mechanical 
ventilation, application of vasoactive drugs, biochemistry, 
blood routine, etc.;
C. Outcome of treatment: survival status within 28 
days in patients with bloodstream infection.
2.3 Data Sorting
The Excel2007 table is used to organize the data, the 
quantitative data is recorded in real values, and the quali-
tative data is assigned. For example, "1" is used for inva-
sive ventilation, and "0" is used for non-invasive ventila-
tion.
According to the acute physiology and chronic health 
status score (APACHE-II score), simplified acute physiol-
ogy score (SAPS-II score), sequential organ failure eval-
uation score (SOFA score), Day-1 and Day1 scores were 
calculated for the enrolled patients.
2.4 Statistical treatment
Excel 2007 form was used to establish the database. SPSS 
17.0 statistical software was used to process the data. The 
two quantitative data were compared using the t test. The 
two qualitative data were compared using the χ 2 test. To 
evaluate the effect of the three scoring systems on the 
prognosis, a receiver operating characteristic curve (ROC 
curve) was drawn. Death related factors were analyzed. 
Univariate analysis was performed using enter method and 
univariate logistic regression. Multivariate analysis was 
performed using the Forward:LR method for multivariate 
unconditional logistic regression analysis. P values, OR 
values, and 95% confidence intervals for OR values were 
calculated. A two-sided test was used. P <0.05 indicates 
that the results are statistically significant.
3. Results
3.1 General Clinical Data
From January 2009 to December 2012, a total of 527 
positive blood culture specimens were collected in the 
geriatric ward of our hospital. After the exclusion of false 
positive cases, a total of 210 patients with nosocomial ac-
quired bloodstream infection were enrolled. The mean age 
of the patients was 87.1 6.7 years (65 ~ 104 years), with 
198 males (94.3%) and 12 females (5.7%). General clini-
cal data are shown in Table 1.
Table 1. General clinical data
Item Hospital acquired bloodstream infec-tion
Age 87.1±6.7
Gender
Male(%) 198(94.3)
Female(%) 12(5.7)
Average maximum temperature (°C) 38.9±0.8
Fever type
Enecia(%) 104(49.5)
Hyperthermia(%) 72(34.3)
Irregular fever(%) 22(10.5)
low-grade fever(%) 11(5.2)
Hypothermia (≤35°C)(%) 1(0.5)
Chill
Yes(%) 122(58.1)
No(%) 88(41.9)
Shock(%)
Yes(%) 56(26.7)
No(%) 154(73.7)
C-reactive protein (mg/dL) 6.75±6.47
White blood cells (10 9 /L) 11.43±6.01
Neutrophil percentage 0.81±0.10
Note: The highest body temperature, C-reactive protein, white blood 
cell, and neutrophil percentage were the highest values for 24 hours of 
infection.
Among the most enrolled patients, the most common 
underlying diseases were: 161 cases (76.67%) of cardio-
vascular diseases, 123 cases (58.57%) of cerebrovascular 
diseases, and 109 cases (51.90%) of pulmonary infections, 
95 cases (45.24%) of parenchymal malignant tumors, 85 
cases (40.48%) of chronic renal insufficiency, 74 cases 
(35.24%) of COPD, 74 cases (35.24%) of diabetes, 27 
cases (12.86%) of chronic bronchitis, 27 cases (12.86%) 
of chronic liver insufficiency and 12 cases (5.71%) of 
hematological tumors. Invasive medical operations and 
others: 165 cases (78.57%) of deep venous indwelling 
DOI: https://doi.org/10.30564/jgr.v1i01.728
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catheter, 139 cases (66.19%) of indwelling gastric tube, 
125 cases (59.52%) of indwelling catheter, 100 cases 
(47.62%) of invasive ventilation, 21 cases (10.00%) of 
thoracoperitoneal catheterization, and 14 cases (6.67%) of 
hemodialysis and 27 cases (12.86%) of ICU.
3.2 Clinical Outcome
The cumulative mortality rates of patients with acquired 
blood flow in elderly at 7 days, 14 days, 21 days, and 28 
days are shown in Table 2.
Table 2. Cumulative mortality in elderly patients with 
acquired bloodstream infection
Time Cumulative mortality
7 days 8.10(17/210)
14 days 11.90(25/210)
21 days 18.10(38/210)
28 days 22.38(47/210)
The overall cumulative mortality of the elderly patients 
with acquired bloodstream infection increased gradually 
with time within 28 days after infection, which showed a 
basically linear distribution. This suggests that the mor-
tality rates at week 1, 2, 3, and 4 are essentially the same. 
In addition, the 28-day mortality from shock was 48.21% 
(27/56).
3.3 Comparison of the value of three system 
scores for prognosis evaluation
Bloodstream infection was observed for 7 days and 28 
days. The survival status of patients was divided into sur-
vival group and death group. The APACHE-II score, the 
SAPS-II score, and the score of the SOFA scoring system 
in Day-1 and Day1 were compared to the prognostic value 
of the above observation endpoint. When the area under 
the ROC curve is equal to 0.5, it is meaningless. When 
the area under the ROC curve is 0.5 ~ 0.7, the evaluation 
effect is general. When the area under the ROC curve is 
0.7 ~ 0.9, the evaluation effect is good. When the area 
under the ROC curve is greater than 0.9, the evaluation 
effect is excellent. For infectious diseases, the higher the 
sensitivity, the higher the value of clinical diagnosis and 
treatment, and the stronger the practicality of prognosis 
assessment. The higher the specificity, the higher the accu-
racy of clinical diagnosis. The death was set to 1 and the 
survival was set to 0. The ROC curves of the above scores 
at 7 days and 28 days are shown in Figure 1 and Figure 2, 
respectively. The 95% confidence intervals for the AUC, 
standard error, P value, and area under each curve for each 
curve are shown in Table 3.
Figure 1. ROC curve
Figure 2. ROC curve
Note: a, b, c, d, e, and f represent Day-1 APACHE-II score, Day1AP-
ACHE-II score, Day-1 SAPS-II score, Day1 SAPS-II score, Day-1 
SOFA score and Day1 SOFA score, respectively.
DOI: https://doi.org/10.30564/jgr.v1i01.728
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Table 3. Area under the ROC curve for APACHE-II score, 
SAPS-II score, and SOFA score
Time Score AUC Standard error P 95% CI
7 days
Day-1APACHE-II 0.910 0.026 0.000 0.859~0.960
Day1APACHE-II 0.900 0.032 0.000 0.837~0.963
Day-1SAPS-II 0.887 0.037 0.000 0.814~0.960
Day1SAPS-II 0.878 0.039 0.000 0.802~0.954
Day-1SOFA 0.903 0.030 0.000 0.843~0.962
Day1SOFA 0.821 0.074 0.000 0.676~0.967
28 days
Day-1APACHE-II 0.687 0.053 0.000 0.584~0.790
Day1APACHE-II 0.687 0.052 0.000 0.584~0.789
Day-1SAPS-II 0.680 0.052 0.000 0.578~0.782
Day1SAPS-II 0.675 0.052 0.000 0.572~0.777
Day-1SOFA 0.713 0.049 0.000 0.616~0.809
Day1SOFA 0.681 0.053 0.000 0.578~0.784
3.4 Univariate Analysis of Death-related Factors
Bloodstream infections were observed for 7 and 28 days. 
The Day-1APACHE-II score >18 was included in the ob-
servational endpoint for 7 days of risk factors. The Day-1 
SOFA score > 7 was included in the observation endpoint 
for 28 days of risk factors. The effects of exposure and 
non-exposure to risk factors on the observed endpoint 
survival status were compared. χ 2 test was performed. 
Risk factors with P < 0.05 were selected. Risk factors 
were analyzed by enter method with single factor logistic 
regression. P, OR and OR 95% CI were calculated and the 
results are shown in Table 4.
3.5 Multivariate analysis of death-related factors
The blood flow was infected for 7 days and 28 days as the 
end point of observation. The patient's survival status was 
taken as the dependent variable (death = 1, survival = 0). 
Factors with P < 0.05 at each observation endpoint in ta-
ble 4 were taken as independent variables. The model was 
established by using forward:LR multi-factor non-condi-
tional logistic regression analysis method (the introduc-
tion probability was 0.05, and the rejection probability 
was 0.10). The results showed that Day-1APACHE-II 
score>18, parenchymal malignant tumors, and concurrent 
shock were independent risk factors for 7-day death in 
elderly patients with acquired bloodstream infection. Day-
1 SOFA score>7, chronic renal insufficiency, and concur-
rent shock are independent risk factors for 28-day death in 
elderly patients with acquired bloodstream infection. The 
specific results are shown in Table 5.
Table 5. Comparison of cognitive function between dia-
betic group and control group
Time Risk factor
Partial 
regression 
coefficient
Stan-
dard 
error
P OR OR95% CI
7 days
Day-
1APACHE-II 
score>18
3.917 1.171 0.001 50.265 5.062~499.095
Parenchymal 
malignant 
tumor
2.091 0.788 0.008 8.096 1.728~37.924
Concurrent 
shock 4.218 1.147 0.000 67.912 7.177~642.632
Constant term -8.976
Table 4. Statistical results of single factors related to death in elderly patients with acquired bloodstream infection
Time Risk factor Partial regression 
coefficient
Standard error P OR OR95% CI
7 days
Day-1APACHE-II score>18 3.642 1.043 0.000 38.175 4.945~294.175
Lung infection 2.067 0.766 0.007 7.898 1.759~35.477
Invasive ventilation 1.376 0.590 0.020 3.960 1.246~12.581
Chronic hepatic insufficiency 1.497 0.558 0.007 4.468 1.498~13.328
Chronic renal insufficiency 2.579 0.768 0.001 13.179 2.928~59.317
Malignant tumors of parenchy-
mal organs 1.081 0.529 0.041 2.948 1.046~8.039
Venous catheterization 1.769 0.703 0.012 5.866 1.478~23.281
Indwelling gastric tube 2.231 1.042 0.032 9.311 1.209~71.708
Indwelling catheter 2.512 1.041 0.016 12.330 1.603~94.849
Concurrent shock 4.114 1.046 0.000 61.200 7.878~475.418
28 days
Day-1SOFA score >7 2.020 0.370 0.000 7.536 3.651~15.555
Chronic hepatic insufficiency 1.219 0.430 0.005 3.383 1.455~7.865
Chronic renal insufficiency 1.243 0.346 0.000 3.465 1.759~6.825
Concurrent shock 1.833 0.359 0.000 6.238 3.086~12.611
Hemodialysis 1.680 0.569 0.003 5.368 1.760~16.370
DOI: https://doi.org/10.30564/jgr.v1i01.728
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28 
days
Day-1SOFA 
score >7 2.269 0.872 0.009 9.667 1.749~53.422
Concurrent 
shock 3.590 1.085 0.001 36.224 4.322~303.605
Chronic renal 
insufficiency
1.706 0.894 0.056 5.506 0.955~31.728
Constant term -7.055
4. Discussion
Risk factors for bloodstream infections include the pa-
tient's underlying disease, medical factors, microbiolog-
ical factors, and environmental factors. Medical factors 
mainly include intravascular catheters, indwelling cath-
eters, endoscopic procedures, and abdominal infection 
drainage tubes [13]. In addition, a multicenter study in the 
Netherlands also found that long stay in ICU before in-
travenous catheterization, intravenous catheterization and 
infusion of intravenous nutrient solution can increase the 
incidence of catheter-related bloodstream infection, and 
intravenous catheterization and infusion of antibiotics can 
reduce the incidence [14]. Other studies have shown that 
the greatest risk factors for catheter-related bloodstream 
infection are neutropenia caused by intravenous infusion 
of nutrient solution and chemotherapy [15-17].
Because this study was a retrospective study, it was 
difficult to find a matched control group, and statistical 
analysis of risk factors for bloodstream infection in elder-
ly patients was not completed. Therefore, only the basic 
diseases of patients and factors such as indwelling ducts 
were preliminarily counted. Cardiac dysfunction, pulmo-
nary infection, chronic hepatic insufficiency, chronic renal 
insufficiency, hematological malignancies, diabetes, pa-
renchymal malignancies, indwelling gastric tube, indwell-
ing catheter, hemodialysis are included as risk factors for 
bloodstream infection. The results showed that 98.57% 
patients were combined with risk factors, and 80.48% pa-
tients were combined with three or more risk factors. This 
is one of the reasons for the high incidence of acquired 
bloodstream infections in the elderly.
Early assessment of the prognosis of bloodstream in-
fection is always the direction of clinical workers. It is 
helpful for clinicians to determine the treatment scope and 
intensity, rationally use medical resources, improve the 
quality of medical care, improve the prognosis of patients, 
and reduce the fatality rate. This study made a statistical 
analysis of the APACHE-II score, SAPS-II score, and 
SOFA score for the prognosis of elderly patients with 
acquired bloodstream infection. Acquired bloodstream 
infections in the elderly patients with 7 and 28 days of the 
Day - 1 APACHE -II score, Day1 APACHE -II score, Day 
1 SAPS II score, Day1SAPS II score, Day 1 SOFA score, 
Day1 SOFA score differences were compared. The results 
showed that P was less than 0.001 and the difference was 
significant. Therefore, the Day-1 APACHE-II score is 
the best for the 7-day prognosis of elderly patients with 
acquired bloodstream infection. The Day-1 SOFA score 
was the best for 28-day prognosis in elderly patients with 
acquired bloodstream infection.
5. Conclusion
The incidence of acquired bloodstream infections in the 
elderly was 1.37%. The 7-day and 28-day mortality rates 
were 8.10% and 22.38%, respectively. Concurrent shock 
is 26.7%. The 28-day mortality rate of concurrent shock 
patients was 48.21%. The best outcome score for the 7-day 
prognosis of elderly patients with acquired bloodstream 
infection was the Day-1APACHE-II score, followed 
by the Day-1 SOFA score. The best score for the 28-
day prognostic assessment was the Day-1 SOFA score. 
Univariate analysis of mortality: Day 1 apache -> 18 II 
score, lung infection, invasive ventilation, chronic hepat-
ic insufficiency, chronic renal insufficiency, substantive 
organ malignant tumor, deep venipuncture, indwelling 
gastric tube indwelling ureter, complicated with shock and 
acquired bloodstream infections in the elderly patients 
with 7 days survival state association is significant. Day-
1 SOFA score>7, chronic liver dysfunction, chronic renal 
insufficiency, concurrent shock, hemodialysis and 28-day 
survival status of patients with acquired bloodstream in-
fection in elderly hospitals were significantly associated. 
Multivariate unconditioned logistic regression analysis 
related to death: Day-1APACHE-II score>18, parenchy-
mal malignant tumors, and concurrent shock are indepen-
dent risk factors for 7-day death in elderly patients with 
acquired bloodstream infection. Day-1 SOFA score>7, 
chronic renal insufficiency, and concurrent shock are in-
dependent risk factors for 28-day mortality in elderly pa-
tients with acquired bloodstream infection.
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